Skip to content

MEDEZORL

Active Private limited companyfounded 2013active for 13 yearsKongolaan 14, 1000 BrusselsKBO/BCE: BE 0538.722.657

Lifetime

11 annual accounts with figures on one time axis
peak of €165,561 in 2015
€68,136▼ 52.8%
peak of €105,984 in 2023
€33,950▼ 64.0%
peak of €358,251 in 2020
€287,523▲ 13.4%
€182,502▼ 32.1%
Board1 name since 2013
1 director
Documentsfilings and deeds
09-02-20269 days late
2025micro format
Gross margin from €144,269 to €68,136Result from €94,229 to €33,950Equity from €253,573 to €287,523Debts from €268,786 to €182,502

Key points

from the 2025 annual accounts

Equity

€287,523 ▲ 13.4%

MEDEZORL has made a profit in every financial year since 2015.

Result

€33,950 ▼ 64.0%
€94,2002024€34,0002025

The result fell in 2025 from €94,229 to €33,950.

Turnover

≈ €200,000 estimated

The micro format states no turnover.

Liquidity

2.21 was 1.62 in 2024

Short-term debts fell from €154,934 to €93,919.

Filings

11 annual accounts since 2015
deadline201520202025

Ten of the last ten came late. The 2019 accounts came in latest, 28 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,817 companies had the same profile as MEDEZORL has now. Each dot stands for 45 companies, two years later.

96.5%
were still trading
3.2%
stopped another way
0.3%
went bankrupt
  • Small
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,817 companies, not a prediction for MEDEZORL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 13-09-2013
  • 100 sharesdeed of 27-09-2013
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0538722657
Registered office moved within Brussels The registered office moved from avenue du Congo, 14 à 1000 Bruxelles to Avenue du Congo 14 boîte 38, 1000 Bruxelles · reappointed as director · General meeting of 29-09-2023 · Gazette deed
Registered office moved within Brussels The registered office moved from avenue Adolphe Buyl, 166 à 1050 Bruxelles to avenue du Congo, 14 à 1000 Bruxelles · Board meeting of 05-02-2015 · Gazette deed
Incorporation Founding capital of €18,600, 100 shares, €15,000 paid up · Founded by · appointed as manager · published on 27-09-2013 · Gazette deed
All 22 events

Official details

Source: KBO
Status
Active since 18-09-2013Normal situation
Registered office
13 active companies are registered at this addressOf these, 1 started in the 12 months before 20 November 2026. Source: KBO register, as of 20 November 2026.
Activity
General medical practiceNACE 86210and 1 other2 activities on the establishment unitFrom the articles
Establishment unit
2.222.444.2041050 Ixelles, since 18-09-2013
Financial year end
30 June
Peppol
Reachable since 09-01-2026
Company details

Annual accounts to 30-06-2025

€470,025▼ 10.0%
Filing
Filed on 09-02-2026
Financials

Insights on MEDEZORL

MEDEZORL files the micro format. That format states no turnover. The gross margin fell from €165,561 in 2015 to €68,136 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDEZORL

What is the company number of MEDEZORL?
The company number of MEDEZORL is 0538.722.657. The VAT number is the same number with BE in front: BE 0538.722.657.
Where is MEDEZORL based?
The registered office is at Kongolaan 14, 1000 Brussels.Company details
What does MEDEZORL do?
According to the KBO register, the main activity of the establishment unit is general medical practice (NACE 86210). The KBO lists 1 more.
What is the legal form of MEDEZORL?
MEDEZORL is a private limited company (BV).
When was MEDEZORL founded?
MEDEZORL was founded on 18-09-2013.
Is MEDEZORL still active?
Yes, MEDEZORL is an active enterprise in the KBO register.
What is the turnover of MEDEZORL?
The turnover in financial year 2025 is about €200,000. This figure is estimated from the gross margin of €68,136 and 2,981 comparable companies of the same size. It probably lies between €130,000 and €350,000. It is a rough estimate.Financials
Is MEDEZORL profitable?
In financial year 2025, MEDEZORL made a profit of €33,950.
Where can I find the annual accounts of MEDEZORL?
MEDEZORL filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDEZORL due?
MEDEZORL must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.